XTL Biopharmaceuticals Price Chart
XTL Biopharmaceuticals Volume Chart
XTL Biopharmaceuticals Market Segments
After Hours
*No Trades in Segment
Regular Trading Hours
-0.0442(-6.85%)
| Open | $0.6452 |
|---|---|
| Close | $0.6010 |
| Low | $0.6000 |
| Low Change | -0.0452 (-7.01%) |
| High | $0.6480 |
| High Change | +0.0028 (+0.43%) |
| Range | $0.0480 |
| Volume | 28.572K |
| Dollar Volume | $17.17K |
Premarket
*No Trades in Segment
After Hours Yesterday
+0.0000(+0.00%)
| Open | $0.6463 |
|---|---|
| Close | $0.6463 |
| Low | $0.6463 |
| Low Change | 0.0000 (0.00%) |
| High | $0.6463 |
| High Change | +0.0000 (+0.00%) |
| Range | $0.0000 |
| Volume | 100 |
| Dollar Volume | $64.63 |
Regular Trading Hours Yesterday
-0.0018(-0.28%)
| Open | $0.6499 |
|---|---|
| Close | $0.6481 |
| Low | $0.6258 |
| Low Change | -0.0241 (-3.71%) |
| High | $0.6499 |
| High Change | +0.0000 (+0.00%) |
| Range | $0.0241 |
| Volume | 10.624K |
| Dollar Volume | $6.89K |
Premarket Yesterday
*No Trades in Segment
XTL Biopharmaceuticals Moving Averages
| 5 Day Moving Average (SMA5) | $0.6736 |
|---|---|
| 10 Day Moving Average (SMA10) | $0.7079 |
| 20 Day Moving Average (SMA20) | $0.7696 |
| 50 Day Moving Average (SMA50) | $0.8280 |
| 100 Day Moving Average (SMA100) | $0.8821 |
| 200 Day Moving Average (SMA200) | $1.1071 |
XTL Biopharmaceuticals Statistics
| Average Volume (30 Days) | — |
|---|---|
| P/E Ratio (Current) | — |
| EPS (Current) | — |
| Dividend Yield | — |
| Free Cash Flow | — |
| Cash Ratio | — |
| Current Ratio | — |
| Quick Ratio | — |
| Debt to Equity | — |
| Enterprise Value | — |
| EV to EBITDA | — |
| EV to Sales | — |
| Price to Book | — |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | — |
| Return on Equity | — |
XTL Biopharmaceuticals Stock Splits
There has been 1 stock split for XTL Biopharmaceuticals (XTLB). The reverse stock split occured on February 10, 2017 and reduced the outstanding shares at a ratio of 5:1.
| Date | Type | Ratio |
|---|---|---|
| Feb 10, 2017 | Reverse | 5:1 |
XTL Biopharmaceuticals Dividends
There have been no dividends for XTL Biopharmaceuticals (XTLB).